DEA Judge Orders Agency To Answer Rescheduling Discovery Request

What the judge ordered, and what the order doesn't do

The judge didn't grant the opponents' request; the order only forces the DEA to put its position on the record.

According to Marijuana Moment, the judge presiding over the hearing on the Trump administration's rescheduling proposal directed the agency to respond to a motion from opponents. They want a new round of testimony and discovery, meaning access to documents and potentially new witnesses.

That's a procedural step. Not a ruling.

The initial reporting reviewed by CannIntel did not include the judge's name, the response deadline, or the identities of every opponent filing the request. We aren't going to guess at them. What is clear is the trigger: a recently released federal watchdog report that, per Marijuana Moment, found "gaps" in how the government evaluates marijuana for scheduling purposes.

Read plainly, the order is housekeeping with consequences. Judges routinely require a response before ruling on a contested motion, but the motion itself, if granted in any form, would reopen a record that proponents of rescheduling want closed.

Why the watchdog report hands opponents an opening

Opponents are using a government finding about process flaws as grounds to reopen the evidentiary record.

Rescheduling under the Controlled Substances Act is supposed to rest on a documented scientific and medical evaluation. The statute, 21 U.S.C. 811, ties scheduling decisions to that evaluation, including input from the Department of Health and Human Services. If a government watchdog says the evaluation process has gaps, opponents get a ready-made argument: the record the DEA is relying on is incomplete.

Whether that argument works is a separate question. The report's gaps, as described, concern the government's process. A judge could decide they don't require new testimony in a hearing that already built its own record. The DEA could say the same.

Still, the tactic is smart. Opponents don't need to win the motion to benefit. They need the agency to spend time answering it, and they need the judge to take it seriously enough to demand a reply.

Even a denied discovery motion creates a paper trail that opponents could cite if the final rescheduling decision is challenged in federal court.

That's the quiet stake here. Hearings produce records, and records are what appellate judges read.

What operators and investors should watch

Any added testimony or discovery would likely push back the timeline for relief that cannabis businesses have priced in for years.

The financial prize is well understood. Marijuana sits in Schedule I, and Section 280E of the tax code bars businesses trafficking in Schedule I and II substances from deducting ordinary operating expenses. Moving marijuana to a lower schedule would remove that exposure for state-licensed operators in markets like California and Ohio. That's why multistate operators (MSOs) track every procedural wrinkle in this hearing.

A new round of testimony wouldn't change the destination. It could change the date. And dates matter for balance sheets: tax reserves, debt covenants and capital-raising plans all assume some timeline for 280E relief.

Three variables will decide how much damage this does:

• How the DEA frames its response, particularly whether it disputes the report's relevance or the need for new witnesses.
• Whether the judge limits any discovery to narrow document requests rather than fresh testimony.
• Whether the FDA and Health and Human Services, whose scientific work underpins the scheduling evaluation, get pulled into the dispute.

For full background on how the hearing reached this point, see the CannIntel topic hub on DEA marijuana rescheduling.

Operators shouldn't read this as a setback yet. But they shouldn't read it as noise either. Procedural fights in federal administrative hearings tend to move slowly, and slow is the one outcome rescheduling backers can least afford.

The next signal is the DEA's filed response and the judge's ruling on it. Those two documents will show whether the watchdog report reshapes the hearing or ends up as a footnote.